PL2722340T3 - Analogi alfa- i gamma-msh - Google Patents

Analogi alfa- i gamma-msh

Info

Publication number: PL2722340T3
Authority: PL; Poland
Prior art keywords: gamma; alpha; msh analogues; msh; analogues
Prior art date: 2012-10-19

Application number

PL13189492T

Other languages

English (en)

Inventor

Thomas Boesen

Original Assignee

Txp Pharma Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-10-19

Filing date

2013-10-21

Publication date

2015-08-31

2013-10-21 Application filed by Txp Pharma Gmbh filed Critical Txp Pharma Gmbh

2015-08-31 Publication of PL2722340T3 publication Critical patent/PL2722340T3/pl

Links

GZWUQPQBOGLSIM-VOOUCTBASA-N γ msh Chemical class C([C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC=1N=CNC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)NCC(O)=O)C(C)C)C1=CC=C(O)C=C1 GZWUQPQBOGLSIM-VOOUCTBASA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
- C07K14/68—Melanocyte-stimulating hormone [MSH]
- C07K14/685—Alpha-melanotropin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
- C07K14/68—Melanocyte-stimulating hormone [MSH]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Toxicology (AREA)
Molecular Biology (AREA)
Zoology (AREA)
Endocrinology (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Immunology (AREA)
Epidemiology (AREA)
Rheumatology (AREA)
Heart & Thoracic Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Pain & Pain Management (AREA)
Urology & Nephrology (AREA)
Cardiology (AREA)
Biomedical Technology (AREA)
Vascular Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Hematology (AREA)
Diabetes (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

PL13189492T 2012-10-19 2013-10-21 Analogi alfa- i gamma-msh PL2722340T3 (pl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US201261716032P	2012-10-19	2012-10-19
EP13189492.5A EP2722340B1 (en)	2012-10-19	2013-10-21	Alpha- and gamma-MSH analogues

Publications (1)

Publication Number	Publication Date
PL2722340T3 true PL2722340T3 (pl)	2015-08-31

Family

ID=49448156

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL13189492T PL2722340T3 (pl)	2012-10-19	2013-10-21	Analogi alfa- i gamma-msh

Country Status (12)

Country	Link
US (3)	US9217023B2 (pl)
EP (2)	EP2944650A1 (pl)
JP (1)	JP6429782B2 (pl)
CN (1)	CN104822702B (pl)
AU (1)	AU2013333765B2 (pl)
CA (1)	CA2888277C (pl)
DK (1)	DK2722340T3 (pl)
ES (1)	ES2538702T3 (pl)
HU (1)	HUE025870T2 (pl)
PL (1)	PL2722340T3 (pl)
RU (1)	RU2668791C2 (pl)
WO (1)	WO2014060606A1 (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2014060606A1 (en)	2012-10-19	2014-04-24	Txp Pharma Gmbh	Alpha- and gamma-msh analogues
WO2015162483A1 (en) *	2014-04-22	2015-10-29	Txp Pharma Gmbh	Alpha- and gamma-msh analogues
WO2015162485A1 (en) *	2014-04-22	2015-10-29	Txp Pharma Gmbh	Peptide analogues with branched amino acid probe(s)
US20170304406A1 (en) *	2014-10-28	2017-10-26	Clinuvel Ag	New indication for alpha-msh analogues
US20170360896A1 (en) *	2014-10-28	2017-12-21	Clinuvel Ag	Inflammatory disease
WO2017068020A1 (en)	2015-10-20	2017-04-27	Txp Pharma Gmbh	W-peptide analog
PT3773558T (pt)	2019-05-10	2022-09-13	Synact Pharma Aps	Tratamento combinado de doença artrítica
CA3190959A1 (en)	2020-08-12	2022-02-17	Txp Pharma Ag	Exendin-4 peptide analogues
US20240287154A1 (en) *	2021-05-27	2024-08-29	The Regents Of The University Of Michigan	Mc3r agonist peptides
AU2022296767A1 (en)	2021-06-21	2024-02-01	Synact Pharma Aps	Phenyl pyrrole aminoguanidine salts and formulations
WO2024030977A2 (en) *	2022-08-03	2024-02-08	Sightstream Biotherapeutics, Inc.	Novel melanocortin analogs
CN117106057B (zh) *	2022-08-19	2024-11-01	南京汉欣医药科技有限公司	一种高纯的人促肾上腺皮质激素或其类似物及其规模化制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4166452A (en)	1976-05-03	1979-09-04	Generales Constantine D J Jr	Apparatus for testing human responses to stimuli
US4356108A (en)	1979-12-20	1982-10-26	The Mead Corporation	Encapsulation process
US4265874A (en)	1980-04-25	1981-05-05	Alza Corporation	Method of delivering drug with aid of effervescent activity generated in environment of use
US5597894A (en)	1995-06-05	1997-01-28	The Louisiana State University Medical Center Foundation	Multi-tyrosinated somatostatin analogs
WO1998027113A2 (en)	1996-12-17	1998-06-25	Quadrant Holdings Cambridge Limited	Melanocortin derivatives for specific binding of melanocortin receptor 3, 4 or 5
AU757658B2 (en) *	1998-03-09	2003-02-27	Zealand Pharma A/S	Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
SE9801571D0 (sv)	1998-05-05	1998-05-05	Wapharm Ab	Melanokortin-1-receptorselektiva föreningar
WO2002006316A2 (en)	2000-07-14	2002-01-24	Zycos, Inc.	Alpha-msh related compounds and methods of use
US8912144B2 (en)	2003-12-16	2014-12-16	Children's Medical Center Corporation	Method for treating stroke via administration of NEP1-40 and inosine
KR100997177B1 (ko) *	2005-07-08	2010-11-29	입센 파마 에스.에이.에스	멜라노코르틴 수용체 리간드
AU2005335905C1 (en) *	2005-08-26	2011-12-22	Abbvie Inc.	Therapeutically active alpha-MSH analogues
WO2014060606A1 (en)	2012-10-19	2014-04-24	Txp Pharma Gmbh	Alpha- and gamma-msh analogues
WO2015162483A1 (en)	2014-04-22	2015-10-29	Txp Pharma Gmbh	Alpha- and gamma-msh analogues
WO2015162486A1 (en)	2014-04-22	2015-10-29	Txp Pharma Gmbh	Linear gamma msh with c- and / or n-terminal extensions of lysine and / or glutamic acid residues
WO2015162485A1 (en)	2014-04-22	2015-10-29	Txp Pharma Gmbh	Peptide analogues with branched amino acid probe(s)

2013
- 2013-10-21 WO PCT/EP2013/071935 patent/WO2014060606A1/en not_active Ceased
- 2013-10-21 US US14/058,790 patent/US9217023B2/en active Active
- 2013-10-21 RU RU2015118576A patent/RU2668791C2/ru active
- 2013-10-21 CN CN201380062117.6A patent/CN104822702B/zh active Active
- 2013-10-21 DK DK13189492.5T patent/DK2722340T3/en active
- 2013-10-21 CA CA2888277A patent/CA2888277C/en active Active
- 2013-10-21 EP EP15157262.5A patent/EP2944650A1/en not_active Withdrawn
- 2013-10-21 HU HUE13189492A patent/HUE025870T2/en unknown
- 2013-10-21 AU AU2013333765A patent/AU2013333765B2/en active Active
- 2013-10-21 EP EP13189492.5A patent/EP2722340B1/en active Active
- 2013-10-21 PL PL13189492T patent/PL2722340T3/pl unknown
- 2013-10-21 ES ES13189492.5T patent/ES2538702T3/es active Active
- 2013-10-21 JP JP2015537289A patent/JP6429782B2/ja active Active
2015
- 2015-11-24 US US14/951,305 patent/US9486495B2/en active Active
2016
- 2016-10-10 US US15/289,562 patent/US9951116B2/en active Active

Also Published As

Publication number	Publication date
RU2668791C2 (ru)	2018-10-02
US9486495B2 (en)	2016-11-08
AU2013333765A1 (en)	2015-05-28
RU2015118576A (ru)	2016-12-10
US20170174738A1 (en)	2017-06-22
JP6429782B2 (ja)	2018-11-28
DK2722340T3 (en)	2015-06-08
CA2888277A1 (en)	2014-04-24
WO2014060606A1 (en)	2014-04-24
EP2722340B1 (en)	2015-03-04
CN104822702B (zh)	2019-07-30
HK1197552A1 (en)	2015-01-23
AU2013333765B2 (en)	2017-12-07
US9217023B2 (en)	2015-12-22
US20140155328A1 (en)	2014-06-05
CN104822702A (zh)	2015-08-05
BR112015008767A2 (pt)	2017-07-04
EP2944650A1 (en)	2015-11-18
EP2722340A1 (en)	2014-04-23
HUE025870T2 (en)	2016-05-30
ES2538702T3 (es)	2015-06-23
JP2015534972A (ja)	2015-12-07
US20160074469A1 (en)	2016-03-17
CA2888277C (en)	2023-09-05
US9951116B2 (en)	2018-04-24

Publication	Publication Date	Title
DK2830816T3 (en)	2020-02-17	Hidtil ukendt coatingkoncept
DK3327112T3 (en)	2020-05-04	Agse-deficient stamme
ZA201503358B (en)	2016-08-31	Structure
PL2882788T3 (pl)	2017-06-30	Pianka łączona
EP2934531A4 (en)	2016-06-15	COMBINATION
EP2935220A4 (en)	2016-04-27	PERI-carbinol
GB201319035D0 (en)	2013-12-11	Spolier structure
EP2911673A4 (en)	2016-05-18	COMBINATION
GB201903206D0 (en)	2019-04-24	n
EP2920142A4 (en)	2016-08-10	MÉTHANOFULLERRÈNES
HUP1300640A2 (en)	2014-05-28	Belt-mounting structure
EP2871919A4 (en)	2015-10-14	STRUCTURE
GB201203307D0 (en)	2012-04-11	Remvox
EP2929195A4 (en)	2016-06-29	MOUNTING ARRANGEMENT
EP2925728A4 (en)	2016-11-02	COMBINATION
EP2908816A4 (en)	2016-06-15	ASSOCIATION
EP2908815A4 (en)	2016-06-22	COMBINATION
GB201209454D0 (en)	2012-07-11	Anti-foul attachment
GB201216524D0 (en)	2012-10-31	Project P
GB201216178D0 (en)	2012-10-24	Combination
GB201220383D0 (en)	2012-12-26	Levels
GB201201782D0 (en)	2012-03-14	Con//ect
AU345893S (en)	2012-12-04	Treehouse
GB201213143D0 (en)	2012-09-05	Corcost-99685963
GB201203453D0 (en)	2012-04-11	TVtidy